Trade Setup Buy Target $5.12 Sell Target $5.94 Trailing Stop 20% Youngevity International, Inc. develops and distributes health and nutrition related products and services in the United States and internationally. It operates in three segments: Direct Selling, Commercial Coffee, and Commercial Hemp. The company offers nutritional supplements, gourmet coffee, weight management products, skincare and cosmetics, […]
Read MoreFor growth investors, stocks making new all-time highs are usually seen as the best kinds of stocks to buy. When new all-time highs happen at the top of a long-term upward trend, many of those same investors get even more excited, because traditional trend analysis usually suggests that those are among the highest-probability signals to […]
Read MoreIllumina Inc. (ILMN) sent shockwaves through the entire S&P 500 on Friday after shares experienced an enormous double-digit loss. Investors quickly panicked after the healthcare diagnostics firm sharply lowered its revenue expectations, an announcement that dragged ILMN to its worst close since June 3. Friday’s drop comes as a huge shock since shares of the […]
Read MoreShares of DaVita Inc. (DVA) plunged to their lowest level in more than two weeks during Tuesday’s session. Investors were negatively reacting to a fresh announcement from President Trump regarding the dialysis and healthcare firm’s primary market, dragging the stock to its worst level since June 20. President Trump is known for having a direct […]
Read MoreIf you’ve followed my highlights in this space, you’ve seen me write on a number of occasions about how my value-focused investing approach tends to make me think in defensive terms under current market conditions. As the major indices are driving to new all-time highs, a lot of growth-oriented folks think that sounds pretty silly; […]
Read MoreThis sector outperforms when the Fed cuts rates, and now may be a good time to buy.
Read MoreThese 2 biotech stocks could see double-digit upside over the next year.
Read MoreThese 3 stocks in the sector could deliver strong returns over the next twelve months.
Read MoreShares of Johnson & Johnson (JNJ) continued lower during Wednesday’s session due to a highly publicized trial against the multinational company in the state of Oklahoma. Investors have been skittish over the lead-up to the trial and its massive implications regarding the nationwide opioid crisis, scaring them into dragging the stock down to its lowest […]
Read MoreThe market’s rally from a low point on Christmas Eve last year has given a lot of investors reason to think that the worst of the correction before that, which tested bear market territory for all of the major market indices, is probably done. With seemingly positive news on the trade front working along with […]
Read MoreTechnology is evolving at a rapid pace, and we’re quickly approaching a future where everything from our daily commutes to going to the doctor will be completely revolutionized. For smart investors, identifying those businesses that are disrupting their industries and ushering in the future can lead to huge returns. Identifying these companies isn’t always easy, […]
Read MoreYou’ve heard the phrase, “be greedy when others are fearful.” Judging by the plunge in stocks this month, I think it’s safe to say investors are spooked. Market sell-offs like we’ve seen in the last few weeks tend to create opportunities, and there are two good opportunities in the healthcare sector that investors can now […]
Read More